KRAS and non-small cell lung carcinoma: The latest NSCLC guideline 2021 V2 edition issued by the national comprehensive cancer network (NCCN) indicated that genes associated with targeted therapy of NSCLC include EGFR, KRAS, ALK, ROS1, MET, BRAF, RET, and NTRK [47].